Cibus Inc. Class A Common Stock (CBUS)

About CBUS

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing…

Sector

Industrials

Industry

Agricultural Chemicals

Employees

118

Website

www.cibus.com/

Fundamentals

1-day range

$1.75$1.89

Market cap

$142.74M

P/E (trailing)

—

P/E (forward)

-2.87

EPS (trailing)

$-1.97

Dividend yield

—

Beta

1.65

Avg. volume

321.8K

Forecasts

3 analyst ratings

Cibus Inc. Class A Common Stock Competitors

Chosen by industry and closest market cap.

• CBUS

  Cibus Inc. Class A Common Stock

  $1.66

  ▼ 0.90%
  Market cap $142.74MP/E —
  $1.09$4.19
• AVD

  American Vanguard Corporation Common Stock ($0.10 Par Value)

  $2.2

  ▲ 0.92%
  Market cap $88.01MP/E —
  $2.03$5.92
• BIOX

  Bioceres Crop Solutions Corp. Ordinary Shares

  $0.4199

  ▲ 3.94%
  Market cap $22.76MP/E —
  $0.3013$2.95
• SMG

  Scotts Miracle-Gro Company (The) Common Stock

  $60.56

  ▼ 0.05%
  Market cap $3.61BP/E 49.61
  $52$75.34
• MOS

  Mosaic Company (The) Common Stock

  $23.61

  ▼ 0.63%
  Market cap $7.46BP/E —
  $19.8$36.99
• CF

  CF Industries Holdings Inc. Common Stock

  $125.76

  ▲ 0.04%
  Market cap $17.93BP/E 8.64
  $75.42$141.96

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 12 Health Care Stocks Moving In Friday's Pre-Market Session
  Benzinga · 8/14/2026
• Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/13/2026
• Transcript: Cibus Q2 2026 Earnings Conference Call
  Benzinga · 8/13/2026
• 12 Health Care Stocks Moving In Thursday's After-Market Session
  Benzinga · 8/13/2026
• Cibus Q2 EPS $(0.29) Misses $(0.26) Estimate, Sales $994.000K Miss $1.704M Estimate
  Benzinga · 8/13/2026

• Craig Wichner · June 8, 2026 · Grant

  1.05M
• Craig Wichner · June 8, 2026 · Grant

  894.3K
• Finn Mark Terrence · June 2, 2026 · Grant

  77.6K
• Gerhard Prante · June 2, 2026 · Grant

  64.7K
• Jean-Pierre Jules Lehmann · June 2, 2026 · Grant

  64.7K
• Craig Wichner · June 2, 2026 · Grant

  77.6K
• Thomas Urban · June 2, 2026 · Grant

  64.7K
• Box Kimberly Ann · June 2, 2026 · Grant

  77.6K
• Moretti August J · June 2, 2026 · Grant

  77.6K
• Rory B. Riggs · June 2, 2026 · Grant

  77.6K
• Carlo Broos · April 24, 2026 · Grant

  114.0K
• Carlo Broos · April 24, 2026 · Grant

  57.0K
• Thomas Urban · April 24, 2026 · Grant

  9.1K
• Noel Sauer · April 24, 2026 · Grant

  76.0K
• Noel Sauer · April 24, 2026 · Grant

  38.0K

Institutional Ownership

March 31, 2026

Total shares held

21.90M

Total value held

$43.06M

Institutional holders

65